Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 6:36 PM ET | Feedback | Site Changes | Help
An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.
View All Commentary (CEPH)
Recs
bouhassi (69.17) Submitted: 6/10/07 11:12 PM : Start Price: $82.37 CEPH Score: 23.03
I had the stock or 5 years will growth slowly
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK